Adrenomedullin requires an intact nitric oxide system to function as an endogenous vasodilator in rat gestation

Hypertension in Pregnancy

Volumn 22, Issue 1, 2003, Pages 9-24

  Witlin, Andrea G ^a,c   Gangula, Pandu R R ^a   Wimalawansa, Sunil J ^b   Grafe, Marjorie ^a   Grady, James J ^a   Yallampalli, Chandra ^a  

^a University of Texas Medical Branch School of Medicine   (United States)

^b Medical School   (United States)

^c UNIVERSITY OF TEXAS MEDICAL BRANCH   (United States)

Author keywords

Adrenomedullin; Growth restriction; L NAME; Nitric oxide

Indexed keywords

ADRENOMEDULLIN; EOSIN; HEMATOXYLIN; N(G) NITROARGININE METHYL ESTER; NITRIC OXIDE; PARAFFIN; VASODILATOR AGENT;

ANGIOGENESIS; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BIRTH WEIGHT; CONTINUOUS INFUSION; CONTROLLED STUDY; DECIDUA; DRUG ACTIVITY; DRUG MECHANISM; FEMALE; GESTATIONAL AGE; HYPERTENSION; IMMUNOHISTOCHEMISTRY; INTRAUTERINE GROWTH RETARDATION; NEWBORN MORTALITY; NONHUMAN; OSMOTIC MINIPUMP; PLACENTA; PREGNANCY; RAT; SYSTOLIC BLOOD PRESSURE; VASODILATATION;

ADRENOMEDULLIN; ANIMALS; BLOOD PRESSURE; DISEASE MODELS, ANIMAL; DOSE-RESPONSE RELATIONSHIP, DRUG; ENZYME INHIBITORS; FEMALE; FETAL GROWTH RETARDATION; FETAL WEIGHT; INFUSIONS, INTRAVENOUS; LITTER SIZE; NG-NITROARGININE METHYL ESTER; NITRIC OXIDE; PEPTIDES; PLACENTA; PRE-ECLAMPSIA; PREGNANCY; RATS; RATS, SPRAGUE-DAWLEY; SYSTOLE; VASODILATOR AGENTS;

EID: 0037275806     PISSN: 10641955     EISSN: None     Source Type: Journal    
DOI: 10.1081/PRG-120016789     Document Type: Article

References (25)

1. Kitamura K, Kangawa K, Kawamoto M, Ichiki Y, Nakamura S, Matsuo H, et al. Adrenomedullin: a novel hypotensive peptide isolated from human pheochromocytoma. Biochem Biophys Res Commun 1993; 192:553-560.
2. Kitamura K, Sakata J, Kangawa K, Kojima M, Matsuo H, Eto T. Cloning and characterization of cDNA encoding a precursor for human adrenomedullin. Biochem Biophys Res Commun 1993; 194:720-725.
3. Kitamura K, Ichiki Y, Tanaka M, Kawamoto M, Emura J, Sakakibara S, et al. Immunoreactive adrenomedullin in human plasma. FEBS Lett 1994; 341:288-290.
4. Macri CJ, Martinez A, Moody TW, Gray KD, Miller MJ, Gallagher M, et al. Detection of adrenomedullin, a hypotensive peptide, in amniotic fluid and fetal membranes. Am J Obstet Gynecol 1996; 175:906-911.
5. Di Iorio R, Marinoni E, Scavo D, Letizia C, Cosmi EV. Adrenomedullin in pregnancy. Lancet 1997; 349:328.
6. Di Iorio R, Marinoni E, Letizia C, Gazzolo D, Lucchini C, Cosmi EV. Adrenomedullin is increased in the fetoplacental circulation in intrauterine growth restriction with abnormal umbilical artery waveforms. Am J Obstet Gynecol 2000; 182:650-654.
7. Moncada S, Higgs A. The L-arginine-nitric oxide pathway. N Engl J Med 1993; 329:2002-2012.
8. Lowenstein C, Dinnerman J, Snyder S. Nitric oxide: a physiologic messenger. Ann Intern Med 1994; 120:227-237.
9. Lyall F, Greer I, Young A, Myatt L. Nitric oxide concentrations are increased in the feto-placental circulation in intrauterine growth restriction. Placenta 1996; 17:165-168.
10. Myatt L, Eis A, Brockman D, Kossenjans W, Greer I, et al. Inducible (type II) nitric oxide synthase in human placental villous tissue of normotensive, preeclamptic and intrauterine growth-restricted pregnancies. Placenta 1997; 18:261-268.
11. Hefler L, Reyes C, O'Brien W, Gregg A. Perinatal development of endothelial nitric oxide synthase-deficient mice. Biol Reprod 2001; 64:666-673.
12. Yallampalli C, Garfield RE. Inhibition of nitric oxide synthesis in rats during pregnancy produces signs similar to those of preeclampsia. Am J Obstet Gynecol 1993; 169:1316-1320.
13. Buhimschi I, Yallampalli C, Chwalisz K, Garfield RE. Pre-eclampsia like conditions produced by nitric oxide inhibition: effects of L-arginine, D-arginine and steroid hormones. Hum Reprod 1995; 10:2723-2730.
14. Molnar M, Suto T, Toth T, Hertelendy F. Prolonged blockade of nitric oxide synthesis in gravid rats produces sustained hypertension, proteinuria, thrombocytopenia, and intrauterine growth retardation. Am J Obstet Gynecol 1994; 170:1458-1466.
15. Yallampalli C, Dong YL, Wimalawansa SJ. Calcitonin gene-related peptide reverses the hypertension and significantly decreases the fetal mortality in pre-eclampsia rats induced by N(G)-nitro-L-arginine methyl ester. Hum Reprod 1996; 11:895-899.
16. Makino I, Shibata K, Makino Y, Kangawa K, Kawarabayashi T. Adrenomedullin attenuates the hypertension in hypertensive pregnant rats induced by N(G)-nitro-L-arginine methyl ester. Eur J Pharmacol 1999; 371:159-167.
17. Witlin AG, Saade GR, Mattar F, Sibai BM. Predictors of neonatal outcome in women with severe preeclampsia or eclampsia between 24 and 33 weeks' gestation. Am J Obstet Gynecol 2000; 182:607-611.
18. Barker DJ, Gluckman PD, Godfrey KM, Harding JE, Owens JA, Robinson JS. Fetal nutrition and cardiovascular disease in adult life. Lancet 1993; 341:938-941.
19. Hack M, Flannery DJ, Schluchter M, Cartar L, Borawski E, Klein N. Outcomes in young adulthood for very-low-birth-weight infants. N Engl J Med 2002; 346:149-157.
20. SAS/STAT Users Guide; Cary, NC: SAS Institute, 2000.
21. Ramsey E. The Placenta of Laboratory Animals and Man; Austin: Holt, Rinehart, and Winston: Austin, 1975.
22. Hayakawa H, Hirata Y, Kakoki M, Suzuki Y, Nishimatsu H, Nagata D, et al. Role of nitric oxide-cGMP pathway in adrenomedullin-induced vasodilation in the rat. Hypertension 1999; 33:689-693.
23. Isumi Y, Minamino N, Katafuchi T, Yoshioka M, Tsuji T, Kangawa K, et al. Adrenomedullin production in fibroblasts: its possible function as a growth regulator of Swiss 3T3 cells. Endocrinology 1998; 139:2552-2563.
24. Ishizaka Y, Ishizaka Y, Tanaka M, Kitamura K, Kangawa K, Minamino N, et al. Adrenomedullin stimulates cyclic AMP formation in rat vascular smooth muscle cells. Biochem Biophys Res Commun 1994; 200:642-646.
25. Witlin AG, Li ZY, Grafe MG, Wimalawansa SJ, Grady JJ, Yallampalli C. Placental and fetal growth and development in late rat gestation is dependent on adrenomedullin. Biol Reprod 2002.